Webinar Leaders

House Speaker

Dasha Kaloujskaia
Research Analyst


Frank Plowden
Account Manager

Speak with our team about Beacon Biomarkers & Assays - Lung Cancer

What is Beacon Lung Cancer?

Our inaugural Beacon Biomarkers & Assays offering focuses on lung cancer, covering all biomarkers, assays and clinical trials investigating targeted therapies within the lung cancer landscape.

From preclinical validation of biomarkers and assays to regulatory interactions and updates to clinical trial data, this module encapsulates everything you need to know about the lung cancer biomarker and assay space.

Find out more

How Beacon Lung Cancer Works

Search the biomarker, assay and trial lung cancer landscape by over 30 unique search filters including:

  • Biomarker biology and classification
  • Assay platform technology
  • Regulatory status
  • Drug target and therapeutic class
  • Disease stage and line of therapy

Customize your search strategy to give you the data you need for your research focus.

Contact Us

What is Beacon?

Our state-of-the-art assay and comprehensive biomarker landscape provide unparalleled insights into this devastating disease, empowering researchers, translational scientists, and bio-pharma companies to make informed decisions and advance patient care.

Learn more about how our  biomarkers, assays, and trials Lung Cancer database solutions can be tailored to your research requirements

Find out more